272 related articles for article (PubMed ID: 19609735)
21. Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice.
Murali SK; Andrukhova O; Clinkenbeard EL; White KE; Erben RG
PLoS Biol; 2016 Apr; 14(4):e1002427. PubMed ID: 27035636
[TBL] [Abstract][Full Text] [Related]
22. Dentoalveolar Defects in the
Zhang H; Chavez MB; Kolli TN; Tan MH; Fong H; Chu EY; Li Y; Ren X; Watanabe K; Kim DG; Foster BL
J Dent Res; 2020 Apr; 99(4):419-428. PubMed ID: 31977267
[TBL] [Abstract][Full Text] [Related]
23. Development of Enthesopathies and Joint Structural Damage in a Murine Model of X-Linked Hypophosphatemia.
Faraji-Bellée CA; Cauliez A; Salmon B; Fogel O; Zhukouskaya V; Benoit A; Schinke T; Roux C; Linglart A; Miceli-Richard C; Chaussain C; Briot K; Bardet C
Front Cell Dev Biol; 2020; 8():854. PubMed ID: 33072734
[TBL] [Abstract][Full Text] [Related]
24. FGF23 and its role in X-linked hypophosphatemia-related morbidity.
Beck-Nielsen SS; Mughal Z; Haffner D; Nilsson O; Levtchenko E; Ariceta G; de Lucas Collantes C; Schnabel D; Jandhyala R; Mäkitie O
Orphanet J Rare Dis; 2019 Feb; 14(1):58. PubMed ID: 30808384
[TBL] [Abstract][Full Text] [Related]
25. High iFGF23 level despite hypophosphatemia is one of the clinical indicators to make diagnosis of XLH.
Igaki JM; Yamada M; Yamazaki Y; Koto S; Izawa M; Ariyasu D; Suzuki E; Hasegawa H; Hasegawa Y
Endocr J; 2011; 58(8):647-55. PubMed ID: 21597229
[TBL] [Abstract][Full Text] [Related]
26. Increased Col10a1 expression is not causative for the phenotype of Phex-deficient Hyp mice.
Yorgan T; Rendenbach C; Jeschke A; Amling M; Cheah KS; Schinke T
Biochem Biophys Res Commun; 2013 Dec; 442(3-4):209-13. PubMed ID: 24269824
[TBL] [Abstract][Full Text] [Related]
27. Pathogenic role of Fgf23 in Hyp mice.
Liu S; Zhou J; Tang W; Jiang X; Rowe DW; Quarles LD
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E38-49. PubMed ID: 16449303
[TBL] [Abstract][Full Text] [Related]
28. The expanding family of hypophosphatemic syndromes.
Carpenter TO
J Bone Miner Metab; 2012 Jan; 30(1):1-9. PubMed ID: 22167381
[TBL] [Abstract][Full Text] [Related]
29. New intragenic deletions in the Phex gene clarify X-linked hypophosphatemia-related abnormalities in mice.
Lorenz-Depiereux B; Guido VE; Johnson KR; Zheng QY; Gagnon LH; Bauschatz JD; Davisson MT; Washburn LL; Donahue LR; Strom TM; Eicher EM
Mamm Genome; 2004 Mar; 15(3):151-61. PubMed ID: 15029877
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity.
Liu S; Rowe PS; Vierthaler L; Zhou J; Quarles LD
J Endocrinol; 2007 Jan; 192(1):261-7. PubMed ID: 17210763
[TBL] [Abstract][Full Text] [Related]
31. Sclerostin Antibody Treatment Increases Bone Mass and Normalizes Circulating Phosphate Levels in Growing Hyp Mice.
Carpenter KA; Ross RD
J Bone Miner Res; 2020 Mar; 35(3):596-607. PubMed ID: 31743490
[TBL] [Abstract][Full Text] [Related]
32. Increased bone volume and correction of HYP mouse hypophosphatemia in the Klotho/HYP mouse.
Brownstein CA; Zhang J; Stillman A; Ellis B; Troiano N; Adams DJ; Gundberg CM; Lifton RP; Carpenter TO
Endocrinology; 2010 Feb; 151(2):492-501. PubMed ID: 19952276
[TBL] [Abstract][Full Text] [Related]
33. Genetic Ablation of Osteopontin in Osteomalacic Hyp Mice Partially Rescues the Deficient Mineralization Without Correcting Hypophosphatemia.
Hoac B; Østergaard M; Wittig NK; Boukpessi T; Buss DJ; Chaussain C; Birkedal H; Murshed M; McKee MD
J Bone Miner Res; 2020 Oct; 35(10):2032-2048. PubMed ID: 32501585
[TBL] [Abstract][Full Text] [Related]
34. CRISPR/Cas9-mediated mutation of PHEX in rabbit recapitulates human X-linked hypophosphatemia (XLH).
Sui T; Yuan L; Liu H; Chen M; Deng J; Wang Y; Li Z; Lai L
Hum Mol Genet; 2016 Jul; 25(13):2661-2671. PubMed ID: 27126636
[TBL] [Abstract][Full Text] [Related]
35. New insights into phosphate homeostasis: fibroblast growth factor 23 and frizzled-related protein-4 are phosphaturic factors derived from tumors associated with osteomalacia.
Kumar R
Curr Opin Nephrol Hypertens; 2002 Sep; 11(5):547-53. PubMed ID: 12187320
[TBL] [Abstract][Full Text] [Related]
36. A novel Phex mutation in a new mouse model of hypophosphatemic rickets.
Owen C; Chen F; Flenniken AM; Osborne LR; Ichikawa S; Adamson SL; Rossant J; Aubin JE
J Cell Biochem; 2012 Jul; 113(7):2432-41. PubMed ID: 22573557
[TBL] [Abstract][Full Text] [Related]
37. Hypophosphatemia and growth.
Santos F; Fuente R; Mejia N; Mantecon L; Gil-Peña H; Ordoñez FA
Pediatr Nephrol; 2013 Apr; 28(4):595-603. PubMed ID: 23179196
[TBL] [Abstract][Full Text] [Related]
38. Role of prostaglandins in the pathogenesis of X-linked hypophosphatemia.
Baum M; Syal A; Quigley R; Seikaly M
Pediatr Nephrol; 2006 Aug; 21(8):1067-74. PubMed ID: 16721588
[TBL] [Abstract][Full Text] [Related]
39. Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations.
Chesher D; Oddy M; Darbar U; Sayal P; Casey A; Ryan A; Sechi A; Simister C; Waters A; Wedatilake Y; Lachmann RH; Murphy E
J Inherit Metab Dis; 2018 Sep; 41(5):865-876. PubMed ID: 29460029
[TBL] [Abstract][Full Text] [Related]
40. Incidence of Complications in 25 Adult Patients With X-linked Hypophosphatemia.
Kato H; Koga M; Kinoshita Y; Taniguchi Y; Kobayashi H; Fukumoto S; Nangaku M; Makita N; Ito N
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3682-e3692. PubMed ID: 33912912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
